Indefinite Delivery Contract SPE2DP25D0004
Award Date
2/14/25
Last Date to Order
2/13/26
Federal Agency
Medical Supply Chain
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of injectable influenza virus vaccines. The potential value of the contract vehicle is $22.6 million to be delivered between February 2021 through February 2022. Several firm fixed price delivery orders were subsequently issued against this contract for vaccine quantities between $778 to $6.6 million to support the Agency's medical countermeasures programs....
The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season. The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Seqirus USA Inc. to supply influenza virus vaccines. Under this contract vehicle, multiple firm fixed price delivery orders were issued for vaccine doses valued between $13,975 to over $12 million each. Places of performance are Seqirus' Summit, New Jersey facility. Periods of performance span from March 2023 through October 2023. The original solicitation sought proposals to supply approximately 3.39...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The $27.5M IDC, which has a period of performance through June 2019, aims to procure approximately 3.6 million doses of injectable influenza vaccine in multi-dose vials and pre-filled syringes for various ages, including pediatric formulations. The contract supports...
This IDV contract, awarded by the Defense Logistics Agency Troop Support, is for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The contract is a single-award indefinite quantity vehicle with a ceiling value of $25,058,634.80 and a period of performance through February 13, 2026. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The...
The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of influenza virus vaccinations. Between June 2020 and November 2020, Seqirus was issued multiple firm fixed price delivery orders against the IDV totaling over $66 million to provide influenza virus vaccines from its Summit, New Jersey facility. The vaccinations were to support the Defense Logistics Agency's medical readiness programs and fulfill requirements...
The federal contract IDV award SPE2DP24D0005 is a single award indefinite delivery contract with a ceiling value of $2,327,325.00, awarded by the Defense Logistics Agency's Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of influenza virus vaccines, with a period of performance through March 12, 2025. A task order with award ID SPE2DP24D0005|SPE2DP24F3249 was issued on March 14, 2024 for a firm fixed price...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Seqirus USA Inc., a global biotechnology company specializing in the development, manufacturing, and delivery of influenza vaccines. The contract, valued at $2,555,130.00, is for the procurement of a wide range of influenza vaccine products, including multi-dose vials, pre-filled syringes, and specialized vaccines for different age groups. The contract is intended...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The $143 million IDC is for the supply of adult influenza vaccines, and a separate $208 million IDC is for pediatric influenza vaccines, to support the CDC's nationwide immunization programs from 2022-2023. Seqirus USA Inc. has also been awarded several other high-value...